HHS Issues First Major Medicare Advantage Compliance Overhaul Since 1999
HHS-OIG released updated Medicare Advantage compliance guidance, the first overhaul in over 25 years.
Why it matters: Legal teams and compliance leaders in healthcare face heightened regulatory expectations and litigation risk. The expansion of program requirements will affect contract management, third-party oversight, and investment strategies for Medicare Advantage stakeholders.
- The Medicare Advantage Industry Segment-Specific Compliance Program Guidance was released Feb. 3, 2026.
- Seven critical risk areas are identified, including marketing, claims accuracy, and third-party oversight.
- Accurate provider directories and compliant marketing payments are explicit priorities.
- Over 35 million Americans are now enrolled in Medicare Advantage, making compliance essential.
The new HHS-OIG compliance guidance for Medicare Advantage Organizations (MAOs) marks the federal government’s most significant update since 1999, reflecting transformative change in the public-private health insurance sector.
- Broad scope: The guidance targets MAOs and all entities working within Medicare Advantage—including providers, vendors, and investors—spotlighting risk in seven key areas: access to care, marketing and enrollment, risk adjustment, quality of care, third-party oversight, vertically integrated organizations, and claims accuracy.
- Fraud and abuse risk: OIG underscores the need for rigorous oversight. For example, risk adjustment processes are flagged as especially vulnerable to fraud, and MAOs are directed to ensure data accuracy and identify suspect trends.
- Provider directory accuracy: Outdated directories can mislead enrollees and constitute grounds for liability under the False Claims Act or regulatory sanctions, increasing litigation exposure for plans with inaccurate data (Alston & Bird analysis).
- Third-party scrutiny: The guidance recommends contract language emphasizing compliance and urges continuous oversight of brokers, agents, and partners. Due diligence and ongoing risk-based reviews are strongly advised.
The OIG also draws attention to the complexities stemming from vertically integrated organizations. In such cases, compliance programs must maintain independence and authoritative oversight of Medicare Advantage functions.
Legal and compliance teams should note that enhanced scrutiny coincides with a surge in federal enforcement, including a renewed False Claims Act Working Group with Medicare Advantage as a top priority.
By the numbers:
- 35 million — Medicare Advantage enrollees as of 2026
- 5.06% — Projected average increase in government payments to MA plans (2025 to 2026)
- 7 — Key compliance risk areas highlighted in the 2026 guidance
Yes, but: The guidance does not detail specific enforcement actions or penalties for non-compliance, and implementation strategies are left to individual organizations.